Amicus Therapeutics, Inc. Profile Avatar - Palmy Investing

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults wit…

Biotechnology
US, Philadelphia [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Amicus Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of FOLD's Analysis
CIK: 1178879 CUSIP: 03152W109 ISIN: US03152W1099 LEI: - UEI: -
Secondary Listings
FOLD has no secondary listings inside our databases.